drugset / Trial / NCT01817790

Assessment of Fluticasone Propionate on Ocular Allergy Symptoms

NCT01817790

Phase 3 Completed 626 enrolled GlaxoSmithKline
RandomizedParallel-groupTriple-blind

Summary

This study is designed to investigate the efficacy of fluticasone propionate (FP) on ocular symptoms associated with allergic rhinitis (AR).

Timeline

Start
2012-12
Primary completion
2013-02
Completion
2013-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Fluticasone propionate Other / unclassified 200 ug Intranasal